# Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

> **NCT07293910** · PHASE2 · RECRUITING · sponsor: **Tanta University** · enrollment: 66 (estimated)

## Conditions studied

- HELICOBACTER PYLORI INFECTIONS
- Helicobacter Infection
- Helicobacter Pylori Gastrointestinal Tract Infection
- Helicobacter Pylori Infected Patients

## Interventions

- **DRUG:** Vonoparazan
- **DRUG:** Vitamin D
- **DRUG:** Probiotic
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin 500 mg
- **DRUG:** Proton Pump Inhibitor (PPI) Therapy

## Key facts

- **NCT ID:** NCT07293910
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-15
- **Primary completion:** 2026-12-20
- **Final completion:** 2026-12-20
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07293910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07293910, "Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07293910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*